Myopathy associated with severe SARS-CoV-2 infection

Myopathy associated with severe SARS-CoV-2 infection

Bibliographic Details
Main Authors:	M.J. Abenza Abildúa, M.T. Ramírez Prieto, R. Moreno Zabaleta, C. Algarra Lucas, C. Pérez López
Format:	Article
Language:	English
Published:	Elsevier España 2020-11-01
Series:	Neurología (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2173580820302133

Similar Items

Miopatía asociada a infección grave por SARS-CoV-2
by: M.J. Abenza Abildúa, et al.
Published: (2020-11-01)

Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious?
by: María José Abenza-Abildúa, PhD, et al.
Published: (2020-09-01)

SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
by: Josef Finsterer, et al.
Published: (2020-12-01)

Complicaciones neurológicas en pacientes críticos por SARS-CoV-2
by: M.J. Abenza-Abildúa, et al.
Published: (2020-11-01)

Reply to ‘SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?’
by: Sergio Bagnato, et al.
Published: (2020-12-01)

Does SARS-CoV-2 truly cause infectious myopathy?
by: Josef Finsterer, et al.
Published: (2021-03-01)

Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature
by: Badrul Islam, et al.
Published: (2021-04-01)

Response to letter to the editor “Does SARS-CoV-2 truly cause infectious myopathy?”
by: Kai Chieh Chang
Published: (2021-03-01)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Detection of SARS-CoV-2 at the point of care
by: Loeffelholz, M.J, et al.
Published: (2021)

Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia
by: Miguel Górgolas Hernández-Mora, et al.
Published: (2021-01-01)

SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
by: Thi Loi Dao, et al.
Published: (2021-06-01)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
by: Wenhan Guo, et al.
Published: (2021-04-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology's COVID-19 Registry
by: M.J. Abenza Abildúa, et al.
Published: (2021-03-01)

Sarilumab use in severe SARS-CoV-2 pneumonia
by: Elisa Gremese, et al.
Published: (2020-10-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity
by: Mackenzie E. Coden, et al.
Published: (2021-06-01)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
by: Ahmed M. Alluwaimi, et al.
Published: (2020-09-01)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
by: Karima A. Al-Salihi, et al.
Published: (2021-01-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Severe SARS-CoV-2 Infection in a Cat with Hypertrophic Cardiomyopathy
by: Francisco R. Carvallo, et al.
Published: (2021-07-01)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
by: Yetian Dong, et al.
Published: (2020-10-01)

Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins
by: Ritesh Gorkhali, et al.
Published: (2021-06-01)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
by: Huibin Lv, et al.
Published: (2020-06-01)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
by: Ma’mon M. Hatmal, et al.
Published: (2020-12-01)

Severe bowel complications in SARS-CoV-2 patients receiving protocolized care
by: S.C. Estevez-Cerda, et al.
Published: (2021-10-01)

In-Flight Transmission of SARS-CoV-2
by: Edward M. Choi, et al.
Published: (2020-11-01)

The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus
by: Castañeda-Delgado, J.E, et al.
Published: (2021)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

Characterization of SARS-CoV accessory proteins
by: Freundt, Eric C.
Published: (2007)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
by: Yue Zheng, et al.
Published: (2021-01-01)

Commentary on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies
by: Tan, A.L., et al.
Published: (2021)

Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection
by: Sheng Feng Tsai, et al.
Published: (2021-04-01)

Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity
by: María Pilar Guallar, et al.
Published: (2020-08-01)

Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19
by: Fei Xiao, et al.
Published: (2020-08-01)